🇺🇸 FDA
Patent

US 6797258

Compositions and methods for the pulmonary delivery of aerosolized macromolecules

expired A61KA61K31/7088A61K31/727

Quick answer

US patent 6797258 (Compositions and methods for the pulmonary delivery of aerosolized macromolecules) held by Nektar Therapeutics expires Mon Sep 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Sep 28 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/7088, A61K31/727, A61K38/1793, A61K38/215